Company / Total Assets
Actinium Pharmaceuticals, Inc. Total Assets History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$51.8M
FY2025
5-year range
$51.8M / $114.2M
FY2021-FY2025
Trend
-32.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has declined for 3 consecutive years, from $114M in FY2022 to $52M in FY2025.
Based on SEC 10-K filings.
$52M in FY2025 with a 3-year CAGR of -23.2%.
Declined from $81M to $52M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -23.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Actinium Pharmaceuticals, Inc.'s total assets has declined for 3 consecutive years.
- 3-year CAGR of -23.2%, indicating a declining trend.
- In FY2025, total assets decreased 32.7% year-over-year.
- Peak total assets was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -8.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $51.8M | -32.7% |
| FY2024 | $76.9M | -5.6% |
| FY2023 | $81.4M | -28.7% |
| FY2022 | $114.2M | +42.1% |
| FY2021 | $80.4M | +1196.5% |
| FY2011 | $6.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026